baber/WOPTO huggingface dataset:
Patent PT-1282557-E (PT)
Inventor: LUEHR STEFANIE
IPC: B65B7/14
Filed: 2001-05-08
Abstract: There is provided an improved method for filling a tube with a paste, ointment, gel or cream along with a device therefore which comprises simultaneously reducing the internal volume of the filled tube with the flattening and closure of the filling orifice.
Patent PT-1313994-E (PT)
Title: Method and plant for manufacturing cement clinker
Inventor: JENSEN LARS SKAARUP
IPC: F27B7/20
Filed: 2001-07-19
Abstract: A description is given of a method as well as a plant for manufacturing cement clinker by which method cement raw meal is preheated in a preheater (1), calcined in a calciner (3) comprising an upper end (3a) and a lower end (3b), burned into clinker in a kiln (5) and cooled in a subsequent clinker cooler (7). The invention is peculiar in that exhaust gases from the kiln (5) are introduced into the upper end (3a) of the calciner, in that fuel is likewise introduced into the upper end (3a) of the calciner, in that the exhaust gas/fuel suspension is directed down through the calciner (3), in that preheated air from the clinker cooler (7) and preheated raw meal from the preheater (1) in combination or separately are fed into the calciner (3) at a location under the zone where exhaust gases from the kiln and fuel are introduced, in that the preheated air is directed down through the calciner (3), being gradually mixed with the exhaust gas/fuel suspension, in that the raw meal under the action of gravity is directed down through the calciner (3) along its wall, being suspended in the exhaust gases at the lower end (3b) of the calciner, and in that the exhaust gas/raw meal suspension is extracted from the lower end (3b) of the calciner and conveyed to a separating means (4) for separating the raw meal which is subsequently directed to the kiln (5). Hereby is obtained a significant reduction of the NOx which is led to the calciner together with the kiln exhaust gases, a high degree of fuel burn out even when using fuels with a low content of volatile constituents, and a low degree of conversion into NOx of the nitrogen which is led to the calciner together with the fuel.
Patent PT-1296715-E (PT)
Title: Multivalent vaccine composition
Inventor: CAPIAU CARINE
IPC: A61P31/14
Filed: 2001-06-27
Abstract: A multi-valent vaccine composition is described comprising a whole-cell pertussis component, tetanus toxoid, diphtheria toxoid, and a low dose of a conjugate of the capsular polysaccharide of  H. influenzae  b.
Patent PT-1358359-E (PT)
Inventor: ERNST CLAUDIA
IPC: C22C38/00
Filed: 2002-01-25
Abstract: The present invention relates to a steel, in particular for tools exposed to corrosion, of the following composition (in mass-%): C: min. 0.02 and max. 0.12%; Si: max. 1.5%; Mn: more than 1.0-2.50%; P: max. 0.035%; S: min. 0.04% and less than 0.15%; Cr: more than 8.0% and less than 12%; Mo: more than 0.0% and max. 0.20%; V: more than 0.0% and max. 0.25%; Nb: more than 0.1% and max. 0.5%; N: at least 0.02% and max. 0.12%; Ni: max. 0.5%; B: max. 0.005%; Cu: max. 0.3%; Al: max. 0.035%; Sn: max. 0.035%; As: max. 0.02%; at least one of the elements Ca, Mg or Ce, wherein the sum of the contents of these elements is at least 0.0002% and max. 0.015%; with the remainder being iron and unavoidable impurities.
Patent PT-1348492-E (PT)
Inventor: WERDINIG HELMUT
IPC: B07B1/18
Filed: 1999-05-17
Abstract: The screening device uses a rod (8) which is wound into a spiral (10). It is rotated is fed into the interior of the spiral, e.g. via a rotary feed drum (2) with the spiral attached to it at one end. The rotary feed drum may be inclined to the horizontal, with the spiral attached to its lower end. The axis of the spiral may be curved downwards due to the spiral weight.
Patent PT-1545565-E (PT)
Title: Compositions comprising mitotically inactivated allogenic fibroblasts and keratinocytes for use in tissue regeneration
Inventor: HUNZIKER THOMAS
IPC: A61K35/36
Filed: 2003-09-05
Abstract: The present invention provides the use and composition of matter of angiogenic or other growth/cytokine factors expressed by mixtures of allogeneic human cell strains or lines of various types and stages of differentiation. Also provided are unencapsulated preparations (mixed with or applied to extracellular matrix material or synthetic biocompatible substances) for the purpose of temporary application to wounds or defects in the skin or other tissues for the restoration of blood supplying connective tissue to enable organ-specific cells to reestablish organ integrity as well as to inhibit excessive scar formation.
Patent PT-1646653-E (PT)
Title: Method of obtaining biologically active collagen from skins of the salmonidae fish
Inventor: PRZYBYLSKI JOZEF
IPC: B01D39/16
Filed: 2003-10-14
Abstract: The method of obtaining collagen as above, is characterized by this, that the process of cleaning the skins is done manually using tools made of natural materials such as glass and wood to remove from the skins scales, skills and meat tissue so prepared raw material is placed in a solution of lactic acid of 0.1 to 1.5% concentration, obtaining hydration of collagen contained in the skins. The hydration process is carried out in glass containers, in the temperature from 15 to 20° C., for 24 to 48 hours, conducting a running visual control of the process. Next follows an operation of filtration using silk filters of increasing density. By repeated filtering the cell elements, pigments and remains of the acid solution are removed from collagen. The natural silk filters have a structure similar to the structure of collagen, which prevents damage to the collagen structure.
Patent PT-1663141-E (PT)
Title: Aqueous pharmaceutical solution containing oxymetazoline and/or xylometazoline
Inventor: ESCHENBACH BERND
IPC: A61K9/00
Filed: 2004-07-14
Abstract: The present invention relates to a stable aqueous solution comprising oxymetazoline and/or xylometazoline, a zinc salt and a buffer salt. The aqueous solution is particularly suitable for local administration into the nose for decongesting the mucous membrane.
Patent PT-1663183-E (PT)
Title: Solid pharmaceutical dosage form comprising ritonavir
Inventor: ROSENBERG JOERG
IPC: A61K9/28
Filed: 2004-08-23
Abstract: A solid pharmaceutical dosage form providing improved oral bioavailability is disclosed for inhibitors of HIV protease. In particular, the dosage form comprises a solid dispersion of at least one HIV protease inhibitor in at least one pharmaceutically acceptable water-soluble polymer and at least one pharmaceutically acceptable surfactant.
Patent PT-1598475-E (PT)
Title: Insect repellent treatment of textiles
Inventor: GRIBOMONT HENRI
IPC: D06M16/00
Filed: 2005-05-18
Abstract: The invention concerns a fabric with insect repellent properties and a method for the manufacturing of a similar fabric in which a solution comprising an insect repellent product and a binding agent on a fabric is provided whereby in the solution an acrylate and a elastomer are added in order to enhance the retention of the insect repellent product on the fabric. Hereby, a fabric is produced that retains its insect repellent properties during successive washes.
Patent PT-1719702-E (PT)
Title: Boarding bridge and method of improving the stability of a boarding bridge
Inventor: SHEN HONGSHENG
IPC: B64D9/00
Filed: 2005-01-25
Abstract: The present invention relates to an auxiliary supporting unit for a boarding bridge, a boarding bridge with the same and method for improving stability of boarding bridge. The auxiliary supporting unit includes a leg support which can be driven to extend and retract; and a foot portion attached to one end of the leg support, wherein the foot portion can be supported on the ground when the leg support being extended and can leave the ground when the leg support being retracted.
Patent PT-1747884-E (PT)
Title: Positive photosensitive lithographic printing plate
Inventor: NAGASAKA HIDEKI
IPC: G03F7/027
Filed: 1997-08-05
Abstract: A positive photosensitive lithographic printing plate which is capable of being operated under white light containing ultraviolet light, said printing plate comprising on a support a positive photosensitive composition which shows, upon scanning exposure to light in the wavelength range from 650 to 1300 nm, by a change other than a chemical change, a difference in solubility in an alkali developer between an exposed portion and a non-exposed portion, characterized in that said composition comprises 
(i) a dye which absorbs said light, 
(ii) an alkali-soluble resin and 
(iii) a solubility-surpressing agent which is capable of lowering 
the dissolution in an alkaline developer of a blend comprising the dye and the alkali-soluble resin, 
with the proviso that the solubility-surpressing agent is not selected from the group consisting of a quinolinium compound, a benzothiazolium compound, a pyridinium compound and an imidazoline compound.
Patent PT-1845093-E (PT)
Title: A new crystalline and stable form of andolast
Inventor: ROVATI LUCIO CLAUDIO
IPC: A61K31/41
Filed: 2006-04-10
Abstract: Described is a new crystalline Form A of Andolast disodium salt, triclinic, displaying a thermal event at 98-112°C and melting with decomposition at about 400°C (DSC). Andolast disodium Form A is a not hygroscopic solid, surprisingly stable to several humidity conditions in a temperature range acceptable for ordinary storage conditions. In addition its stability allows both chemical manufacturing and pharmaceutical manufacturing process consistency and reproducibility under conditions more viable and less expensive when compared to those used for highly hygroscopic solids.
Patent PT-1736194-E (PT)
Title: Implantable medical device with indicator for movable retention members
Inventor: HUNT JOHN V
IPC: A61M39/02
Filed: 2006-06-23
Abstract: An attachment mechanism for a surgically implantable medical device includes one or more fasteners which may be simultaneously moved from an undeployed position to a deployed position by operation of an integral actuator. The attachment mechanism may be configured to be deactuated, and the fasteners simultaneously moved from a deployed position to an undeployed position, allowing removal or repositioning of the medical device. An applier includes a locator for detachably holding the implantable medical device, locating it at the desired position, and actuating the attachment mechanism. The applier is configured to undeploy the attachment mechanism the implantable medical device can be detached from the body tissue.
Patent PT-642581-E (PT)
Inventor: TITBALL RICHARD WILLIAM
IPC: C12N15/31
Filed: 1993-05-20
Abstract: The present invention provides novel peptides and vaccines containing them capable or inducing production of antibodies directed against Clostridium perfringens alph-toxin (CPa) in animals to which the) arc administered and thereby providing pro-phylazis against infection by Clostridium pefringens and/or the alpha-toxin itself. Particularly the present invention provides such a vaccine that is relatively safe and simple to produce. e.g. by genetic engineering means. Preferred peptides comprise theo amino acid sequence of Clostridium perfringens alpha-toxin from amino acid 247 to 370 but lack the epitopes necessary for phos-pholipase C and/or sphingomyelin hydrolysing activity round between amino acids 1 to 240 of that sequence. Further provided are antisera and antibodies raised to the peptides and vaccines of the present invention, and particularly monoclonal antibodies and hybridoma cell lines for their production.
Patent PT-698388-E (PT)
Inventor: CANTORO AMALIO
IPC: A61K33/06
Filed: 1995-07-21
Abstract: Ophthalmic preparation for use as artificial tear containing hyaluronate as a viscosity thickener, preferably in the form of sodic salt and having a molecular weight of 500,000 to 4,000,000 daltons, at a concentration of 0.05 to 2% by weight, as well as the following minimum quantities of ionic species: 40 mmol/l sodium ion, 12 mmol/l potassium ion, 0.4 mmol/l calcium ion, 0.4 mmol/l magnesium ion, 50 mmol/l chloride ion, 7 mmol/l phosphate ion and, preferably, 0.7 mmol/l citrate ion. The formulation, which as an osmolarity of 140 to 280 mOsm/l, is useful for the treatment of keratoconjunctivitis sicca and may be administered whenever the use of artifical tears is advisable, e.g. for the treatment of eye irritations caused by environmental conditions or contact lenses.
Patent PT-749131-E (PT)
Inventor: SEIBERT GERHARD
IPC: H01B13/02
Filed: 1996-06-01
Abstract: Wires (1) of circular or esp. non-circular cross-section are twisted together without back-twisting to form a cable with alternating twist. The twisting head (3) guides each wire in an arc shape over guide rollers (5). The roller profile is adapted to suit the cross-section of the wire (1).
Patent PT-770533-E (PT)
Inventor: FREDERICH FRITZ
IPC: B61F3/16
Filed: 1996-10-21
Abstract: The steering guides a vehicle on a predetermined course (4) using two adjacent wheels (1,2). The steering motions which are necessary to maintain the course, are produced by driving and braking torques of equal magnitudes and opposing directions. The motions act simultaneously on the adjacent wheels of the vehicle or bogey, so that driving and braking forces of equal magnitudes and opposing directions arise at the contact points on the wheels, to create a steering moment. The driving and braking torques may be produced by separate generators.
Patent PT-796049-E (PT)
Inventor: GASSIES CHRISTOPHE
IPC: A44C21/00
Filed: 1996-10-07
Abstract: PCT No. PCT/FR96/01558 Sec. 371 Date Dec. 20, 1996 Sec. 102(e) Date Dec. 20, 1996 PCT Filed Oct. 7, 1996 PCT Pub. No. WO97/13424 PCT Pub. Date Apr. 17, 1997The gambling chip 10, having the general shape of a disc, includes two identical half-discs 11 and 12 in contact via axial spacing rings 21 and 22 respectively located on their internal faces. The half-discs 11 and 12 made of rigid plastic are fastened together by injection of a plastic seal 14 on the edge 35 of the chip into a peripheral annular region 16 lying between the two half-discs 11 and 12. The half-discs 11 and 12 have a central recess 26, 27 forming an internal central region 28 taking an electronic identification device 30 embedded in a wafer based on epoxy resin.
Patent PT-983803-E (PT)
Inventor: SAKTI GHOSH DIPL ING
IPC: A61F5/44
Filed: 1998-08-31
Abstract: Granular material carried in wadding or fiber batts, e.g. absorbers in cellulose nappies, is separated by breaking up the wadding by accelerating it through an air jet (1) and passing the tufts over a series of vibrating screens (2) with sieving surfaces (3). Th granular material falls into a chute (4) and is collected in a vibrating collecting channel (5).
Patent PT-1018341-E (PT)
Inventor: MASUYAMA AKIHIRO
IPC: A23L1/305
Filed: 1998-02-05
Abstract: Antistress agent containing as the active ingredient tripeptides, in particular, Ile-Pro-Pro and/or Val-Pro-Pro, having the activity of inhibiting angiotensin converting enzymes and/or salts thereof, and functional foods containing these antistress agents. These agents and foods can be continuously taken everyday without causing any problem in safety and can relieve and prevent mental and physical symptoms caused by stress.
Patent PT-983366-E (PT)
Inventor: THIREOS GEORGE
IPC: C12N1/15
Filed: 1998-05-20
Abstract: The present invention relates to nucleic acids comprising a nucleotide sequence encoding at least a portion of an enzyme which catalyzes the synthesis of chitin in arthropods, inhibitors directed to said enzyme, and a method for developing said inhibitors.
Patent PT-1034298-E (PT)
Title: Humanization of murine antibody
Inventor: BARBAS CARLOS F III
IPC: C07K16/28
Filed: 1998-12-04
Abstract: A humanized murine antibody is provided. The amino acid sequences of a light chain complementarity determining region from a mouse antibody are grafted onto a human light chain, and a heavy chain complementarity determining region from a mouse antibody are grafted onto a human antibody heavy chain to produce libraries from which a humanized murine antibody having the desired specificity is selected.
Patent PT-935021-E (PT)
Inventor: GRAFF PIERRE
IPC: B31F1/07
Filed: 1999-02-05
Abstract: The domestic two-ply absorbent paper material, with an embossed patterning and in a weight of 10-40 g/m<2>, has a raised point density in each ply of ≥ 10 points/cm<2>, and the surface area of the raised points in each ply is ≥ 5% of the ply surface. At least one ply is embossed with a decorative pattern, with structured projection gaps and angles, which match up with the embossed projections of the other ply. The total surface of the peaks of the projections, bonded together, are at least 15% of the total projection peak surface area of the ply, at the relative positions for the pattern of the two plys. At least 30% or 40% of the embossed projections of one ply form bonds with the embossed projections of the other ply. The total surface of the projection peaks, in a ply, is at least equal to 20% of the projection surfaces of the ply, and is ≤ 30% of the ply surface area and ≥ 7.5% of the ply surface while ≤ 15%. The projection density is preferably ≤ 20 projections/cm<2>. Both plys are embossed with a decorative pattern which can be identical and offset, or different.
Patent PT-1054887-E (PT)
Inventor: NORMAN MARK H
IPC: A61K31/505
Filed: 1999-02-05
Abstract: There are provided compounds, compositions and methods of use thereof in the modulation of feeding behavior, obesity, diabetes, cancer (tumor), inflammatory disorders, depression, stress related disorders, Alzheimer's disease and other disease conditions.
Patent PT-1071955-E (PT)
Inventor: MAERTENS GEERT
IPC: C12N9/00
Filed: 1999-04-15
Abstract: The present invention relates to a method for purifying a cysteine containing recombinantly expressed protein comprising at least 2, preferably 3 or 4 and even more preferably all of the following steps:  (a) sulphonation of a lysate from recombinant host cells or lysis of recombinant host cells in the presence of guanidinium chloride followed by a subsequent sulphonation of the cell lysate, (b) treatment with a zwitterionic detergent, preferably after removal of the cell debris, (c) purification of the sulphonated version of the recombinant protein or purification of the sulphonated version of the recombinant protein with subsequent removal of the zwitterionic detergent, with said purification being preferably chromatography, more preferably a Ni-IMAC chromatography with said recombinant protein being a His-tagged recombinant protein, (d) desulphonation of the sulphonated version of the recombinant protein, preferably with a molar excess of DTT, (e) storage in the presence of a molar excess of DTT.
Patent PT-1140019-E (PT)
Inventor: MODI PANKAJ
IPC: A61K38/00
Filed: 1999-12-16
Abstract: A mixed micellar aerosol pharmaceutical formulation is provided. The formulation comprises a pharmaceutical agent, an alkali metal alkyl sulphate, at least three micelle-forming compounds, a phenol and a propellant. The propellant provides enchanced absorption of the pharmaceutical agent in the buccal region. A process of making and a method of administering the composition are also included.
Patent PT-1133558-E (PT)
Title: Compositions and methods for increasing bone mineralization
Inventor: NESS JEFFREY VAN
IPC: C12Q1/6883
Filed: 1999-11-24
Abstract: Novel proteins and nucleic acids are disclosed. The proteins regulate bone mineralisation, and inhibitors of the proteins, such as antibodies, are useful in treating diseases of low bone mineral density such as osteoporosis.
Patent SG-42190-G (SG)
Title: Method for the colorimetric determination of polygarboxylates and sulphonates inaqueous systems
IPC: G01N31/22
Filed: 1990-06-19
Abstract: The concentration of sulphonate and or polycarboxylate compounds in an aqueous solution is determined by adjusting the pH of a portion of the aqueous solution to less than 3.0 when measuring sulphonate concentration or to between 3.0 and 12.0 when measuring polycarboxylate concentration; adding an effective amount of an aqueous solution of a metachromatic dye to the pH-adjusted portion; measuring the absorbency of the resulting admixture at a wavelength between 300 nm and 700 nm; and comparing this absorbency with absorbencies of standard samples containing known concentrations of polycarboxylate compounds and or sulphonate compounds, thereby determining the desired sulphonate and/or polycarboxylate concentration.
Patent SG-59590-G (SG)
Title: Magnetic tape cassette case
IPC: G11B23/023
Filed: 1990-07-19
Abstract: A magnetic tape cassette box with an indicator device which shows whether or not the box contains a cassette. The indication is provided visibly and/or palpably in that region of the box which is always accessible for the insertion or removal of a cassette.
Patent IE-38777-L (IE)
Title: Optical antipodes of pantolactone
IPC: C07C59/10
Filed: 1974-01-22
Abstract: 1395458 Optical resolution of D,L-pantolactone JENAPHARM VEB 29 Oct 1973 [4 June 1973] 50169/73 Heading C2C The optical resolution of D,L-pantolactone is effected by converting the latter into D,L- lithium pantoate, resolving this racemic salt by selective crystallization from a polar solvent (e.g. CH 3 OH, C 2 H 5 OH) or by electrostatic separation of the racemic mixture crystallized from a polar solvent and subsequently converting the optically-active forms of lithium pantoate thus produced into optically-active pantolactone. The undesired optically-active form of lithium pantoate obtained as a by-product is preferably dissolved or suspended in a polar solvent (e.g. H 2 O, CH 3 OH, C 2 H 5 OH) and racemized at an elevated temperature (e.g. 120-180‹ C.) and optionally in the presence of a basic catalyst (e.g. an aliphatic amine or an alkali metal hydroxide or carbonate). The D,L-lithium pantoate is obtained by reacting D,L-pantolactone with a basic lithium compound (e.g. LiOH, Li 2 CO 3 ) in a polar solvent or by the double decomposition of an appropriate pair of salts (e.g. calcium pantoate/lithium oxalate, barium pantoate/lithium sulphate) in an aqueous medium.
[GB1395458A]
Patent IE-780419-L (IE)
Title: Handling and baiting long fishing lines
IPC: A01K91/18
Filed: 1978-03-28
Abstract: Hooks 26 spaced apart along a line, such as is used in "long line" fishing, are baited by drawing the line through an elongated tubular member 11 into which bait is fed, and having an inlet and an outlet for the line to pass into and out of the tubular member. A blocking device in the form of a brush-assembly 31 having flexible brush- bristles 37 is provided in association with the outlet of the tubular member, so as to retain a mass of bait in the tubular member, while allowing bait which has been impaled by the hooks as the line passes through the tubular member, to pass freely out of the outlet. <IMAGE>
[GB2016881A]
Patent IE-38979-L (IE)
Title: Tetrazolyl - quinoxalinecarboxamide derivatives
IPC: C07D403/12
Filed: 1974-03-07
Abstract: Compounds of the general formula I:  (I) and pharmaceutically acceptable salts thereof in which: (From US3997535 A) [GB1408675A]
Patent FI-845066-L (FI)
Inventor: ROHDE RALPH
IPC: C07J1/00
Filed: 1984-12-20
Abstract: 11 beta -Arylestradienes of general Formula I are disclosed <IMAGE>  (I)  wherein R2 is a hydrogen atom, a methyl group, or an ethyl group, R3 is a hydrogen atom or an acyl group, R1 and A-B have various meanings, which possess antigestagen and antimineralocorticoid activity.
Patent FI-853018-L (FI)
Inventor: PLANK JOHANN
IPC: C08G6/02
Filed: 1985-08-06
Abstract: The present invention provides metal compounds of acid group-containing condensation products or co-condensation products of ketones and aldehydes, obtainable by the reaction of acid group-containing ketone-aldehyde condensation products and/or co-condensation products with mono- or polyvalent metal compounds and/or metal complex compounds of metals of Groups IIIA to VIIIA and/or IB to VB of the Periodic System. The present invention also provides processes for the production of these metal compounds, which can be used as thickening agents, surface-active agents, emulsifiers, dispersion agents and/or liquefying agents, especially in aqueous systems.